Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
about
TRP channel regulates EGFR signaling in hair morphogenesis and skin barrier formationEpidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 proteinCalcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signalingStaphylococcus aureus α-toxin: nearly a century of intrigueTargeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunitiesPhosphatidylserine exposure is required for ADAM17 sheddase functionCytoplasmic relaxation of active Eph controls ephrin shedding by ADAM10Rhomboids, signalling and cell biologyA Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous SystemsADAM9 is involved in pathological retinal neovascularizationProteomic identification of ADAM12 as a regulator for TGF-β1-induced differentiation of human mesenchymal stem cells to smooth muscle cellsPhenotypic diversity of breast cancer-related mutations in metalloproteinase-disintegrin ADAM12PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways.Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10Ectodomain Shedding by ADAM17: Its Role in Neutrophil Recruitment and the Impairment of This Process during SepsisSAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.ADAM12 and ADAM17 gene expression in laser-capture microdissected and non-microdissected breast tumors.Stimulation of platelet-derived growth factor receptor beta (PDGFRbeta) activates ADAM17 and promotes metalloproteinase-dependent cross-talk between the PDGFRbeta and epidermal growth factor receptor (EGFR) signaling pathways.TACE/ADAM17 is essential for oligodendrocyte development and CNS myelination.Interleukin-1 stimulates ADAM17 through a mechanism independent of its cytoplasmic domain or phosphorylation at threonine 735iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPSCD23 Sheddase A disintegrin and metalloproteinase 10 (ADAM10) is also required for CD23 sorting into B cell-derived exosomes.Induction of RAGE shedding by activation of G protein-coupled receptors.Characterization of oxygen-induced retinopathy in mice carrying an inactivating point mutation in the catalytic site of ADAM15.Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivoConditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones.TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.Membrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.The ADAM17-amphiregulin-EGFR axis in mammary development and cancer.Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.Epidermal growth factor (EGF) ligand release by substrate-specific a disintegrin and metalloproteases (ADAMs) involves different protein kinase C (PKC) isoenzymes depending on the stimulusThe Coxsackievirus and Adenovirus Receptor (CAR) undergoes ectodomain shedding and regulated intramembrane proteolysis (RIP).Alternative mRNA splicing generates two distinct ADAM12 prodomain variants.Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.ADAM-mediated amphiregulin shedding and EGFR transactivation.
P2860
Q24307266-078DC6B2-46C9-4E10-9217-7D4E74FA96A8Q24314713-87E2E1F4-357C-400A-B88B-3139A57E0C40Q24602862-2F185846-157B-4E5A-BAAC-4B97272F26DFQ26823686-2D94131C-D6E4-430D-9FC3-FEE2722C0E2BQ27027433-E1A48679-2C8C-4FC0-90A4-ECBF6EF046A0Q27317119-94B9FD65-5918-43E9-BC20-DD07914336A0Q27326381-4ECCA686-AA6A-4942-B684-6E5E1AEB493FQ28070034-1B5D1D69-1917-4588-AF8C-8F6875680446Q28072451-D6C69772-EF39-47EB-A879-578A7CE46626Q28591506-D9F2918A-9338-4F62-B4C2-5E774424C6B4Q28727037-E7DAA5B3-F069-4C54-82AD-0199404D1C17Q30360467-D43CDA4B-5A47-4E0B-9F77-A409AF3BFBE7Q31001916-4275E263-0F4F-49CF-88AB-8DA50AADBD6EQ33407630-8AF8B602-2D16-4F47-A73B-407B3312C69EQ33498106-C794A6DD-7E47-4A13-ACC9-D58F4B04093FQ33599723-481B43D1-3320-4829-971B-9EEFE4F2C57DQ33645235-FD552AC4-9EE3-4D33-8C92-DD9B354C4A86Q33704501-0B97570C-41A1-40E7-A85C-334DF26E419CQ33794994-3DD395DC-8CD9-4F9D-99F1-07C37B026ECDQ34042804-02FBAFB7-1772-47B8-8511-6CAD14D4D885Q34123782-CA87D0E4-D238-4C5A-A136-3665DDF2F20AQ34181792-43AA6BC7-3B41-4AEE-88CF-8D5FE1CD19C0Q34247201-9576587D-FC8C-4E91-B9A0-2AC8B81C32DDQ34333685-BAB43330-289C-4DF5-963E-9D90947DA9B0Q34364237-D4266F84-7018-46C0-B3B1-1B3A0E5CEECCQ34406075-448DB7B9-2C8E-41BF-8402-6CECC6525C08Q34513677-44C2F33D-D33C-4991-A053-7FA45CFD4D59Q34526248-53E8AAFE-5D15-4C1A-9EAC-77DB4D0CB11DQ34559443-5C0D28C8-2F18-4AB2-A52E-D62178DD5A93Q34563518-CF3E16BD-C720-4077-9267-89BD9A719D5EQ34626693-46006483-1842-4F41-B7FA-CEC59854E262Q34646774-280B7CB4-32FF-4C12-9771-C04DC0413691Q34749765-E8A50FFE-1D41-4B45-9A54-64E0D9E4E3E1Q34777834-F67FD7AA-6B94-45F4-9F6C-B340156016A8Q34781580-593F1929-8BBB-4307-93E5-E551A8BDB8B0Q34978954-9314CAB1-4BF4-4DB2-B434-557DA37033F6Q34981717-51728C6E-292C-40AB-8D25-BC3425F53E3EQ35014541-2A6AF64E-51C7-4561-AC86-C3E46C1866B3Q35018592-17FF9C5C-8647-40C8-86EE-5B99596C5997Q35197805-AB7BA280-4058-477C-97A9-CCB6EDA2E50A
P2860
Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Substrate selectivity of epide ...... bol esters and calcium influx.
@ast
Substrate selectivity of epide ...... bol esters and calcium influx.
@en
type
label
Substrate selectivity of epide ...... bol esters and calcium influx.
@ast
Substrate selectivity of epide ...... bol esters and calcium influx.
@en
prefLabel
Substrate selectivity of epide ...... bol esters and calcium influx.
@ast
Substrate selectivity of epide ...... bol esters and calcium influx.
@en
P2093
P2860
P356
P1476
Substrate selectivity of epide ...... bol esters and calcium influx.
@en
P2093
Carl P Blobel
Dieter Hartmann
Gillian Murphy
Karina Reiss
Marc Schulte
Paul Saftig
Sylvain Le Gall
Takafumi Yamaguchi
Yoshiaki Toyama
P2860
P304
P356
10.1091/MBC.E06-01-0014
P577
2006-11-01T00:00:00Z